RecruitingNCT04844151
Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
1,400 participants
Start Date
Jan 23, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.
Eligibility
Min Age: 15 Years
Inclusion Criteria2
- Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.
- affiliation to the French Health Care System "Sécurité sociale"
Exclusion Criteria4
- Severe valvulopathy
- Complex congenital cardiopathy
- Previous heart transplant
- Known significative coronary disease
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04844151
Related Trials
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT0615869810 locations
The Heart Hive - Cardiomyopathy Study
NCT046122961 location
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
NCT050460021 location
The Application of T1 Mapping in Real-World
NCT073546461 location
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
NCT044441281 location